128 related articles for article (PubMed ID: 36327023)
1. Expression analysis of circulating miR-22, miR-122, miR-217 and miR-367 as promising biomarkers of acute lymphoblastic leukemia.
Hosseinpour-Soleimani F; Khamisipour G; Derakhshan Z; Ahmadi B
Mol Biol Rep; 2023 Jan; 50(1):255-265. PubMed ID: 36327023
[TBL] [Abstract][Full Text] [Related]
2. [Association between expression of plasma miRNA and the risk of childhood acute lymphocytic leukemia].
Yuan DM; Wu SY; Huang SL; Jiang WC; Ke YB
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1252-1258. PubMed ID: 28910942
[No Abstract] [Full Text] [Related]
3. Expression pattern of
Chu X; Wu D; Zhang C; Hu S
Scand J Clin Lab Invest; 2023 Jul; 83(4):207-211. PubMed ID: 37093849
[TBL] [Abstract][Full Text] [Related]
4. Distinct power of bone marrow microRNA signatures and tumor suppressor genes for early detection of acute leukemia.
Memari F; Tavakolpour V; Mohajeri N; Poopak B; Fallah P; Alizadeh E; Kouhkan F; Zarghami N
Clin Transl Oncol; 2022 Jul; 24(7):1372-1380. PubMed ID: 35247197
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia.
Fayyad-Kazan H; Bitar N; Najar M; Lewalle P; Fayyad-Kazan M; Badran R; Hamade E; Daher A; Hussein N; ElDirani R; Berri F; Vanhamme L; Burny A; Martiat P; Rouas R; Badran B
J Transl Med; 2013 Feb; 11():31. PubMed ID: 23391324
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia.
Rzepiel A; Kutszegi N; Gézsi A; Sági JC; Egyed B; Péter G; Butz H; Nyírő G; Müller J; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
J Transl Med; 2019 Nov; 17(1):372. PubMed ID: 31727091
[TBL] [Abstract][Full Text] [Related]
7. Value of serum miR-922 and miR-506 expression levels in the diagnosis and prognostic assessment of childhood acute lymphoblastic leukemia.
Zhu YY; Wu RN; Li X; Chen XB
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1021-1026. PubMed ID: 34719417
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
10. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
11. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
13. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
[TBL] [Abstract][Full Text] [Related]
16. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
18. Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma.
Rafiee R; Razmara E; Motavaf M; Mossahebi-Mohammadi M; Khajehsharifi S; Rouhollah F; Babashah S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S383-S390. PubMed ID: 36510992
[TBL] [Abstract][Full Text] [Related]
19. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
[TBL] [Abstract][Full Text] [Related]
20. Serum Exosomal MicroRNAs as Potential Circulating Biomarkers for Endometriosis.
Zhang L; Li H; Yuan M; Li D; Sun C; Wang G
Dis Markers; 2020; 2020():2456340. PubMed ID: 32076458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
